Matjaž Rokavec

2.6k total citations · 2 hit papers
30 papers, 1.9k citations indexed

About

Matjaž Rokavec is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Matjaž Rokavec has authored 30 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 17 papers in Cancer Research and 15 papers in Oncology. Recurrent topics in Matjaž Rokavec's work include MicroRNA in disease regulation (9 papers), RNA modifications and cancer (8 papers) and Cancer-related molecular mechanisms research (7 papers). Matjaž Rokavec is often cited by papers focused on MicroRNA in disease regulation (9 papers), RNA modifications and cancer (8 papers) and Cancer-related molecular mechanisms research (7 papers). Matjaž Rokavec collaborates with scholars based in Germany, United States and Slovenia. Matjaž Rokavec's co-authors include Heiko Hermeking, Huihui Li, David Horst, Markus Kaller, Longchang Jiang, Jiang Lin, Meryem Gülfem Öner, Julia Slotta‐Huspenina, Sarah Schwitalla and Franz G. Bader and has published in prestigious journals such as Journal of Clinical Investigation, Molecular Cell and The Journal of Immunology.

In The Last Decade

Matjaž Rokavec

29 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

IL-6R/STAT3/miR-34a feedback loop promotes EMT-mediated colorectal cancer invasion and metastasis

2014 626 citations Matjaž Rokavec, Meryem Gülfem Öner et al. profile →
Curcumin activates a ROS/KEAP1/NRF2/miR-34a/b/c cascade to suppress colorectal cancer metastasis

2023 124 citations Matjaž Rokavec, Heiko Hermeking et al. Cell Death and Differentiation profile →

Peers

Matjaž Rokavec

ONCOL

IMMUN

PRM

Giridhar Mudduluru Germany

Kuo‐Tai Hua Taiwan

Xian Lin China

Pu Li China

Guopei Zheng China

Juanjuan Shan China

Mei Yi China

Xiaodi Zhao China

Yong Gao China

Giridhar Mudduluru Germany

Matjaž Rokavec

1.6k ×1.3

1.1k ×1.0

437 ×0.7

ONCOL

327 ×1.3

IMMUN

126 ×0.8

PRM

Citations per year, relative to Matjaž Rokavec Matjaž Rokavec (= 1×) peers Giridhar Mudduluru

Countries citing papers authored by Matjaž Rokavec

Since Specialization

Citations

This map shows the geographic impact of Matjaž Rokavec's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matjaž Rokavec with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matjaž Rokavec more than expected).

Fields of papers citing papers by Matjaž Rokavec

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matjaž Rokavec. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matjaž Rokavec. The network helps show where Matjaž Rokavec may publish in the future.

Co-authorship network of co-authors of Matjaž Rokavec

This figure shows the co-authorship network connecting the top 25 collaborators of Matjaž Rokavec. A scholar is included among the top collaborators of Matjaž Rokavec based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matjaž Rokavec. Matjaž Rokavec is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rokavec, Matjaž, et al.. (2025). Down-regulation of RBM47 due to diminished activation by forkhead box A1 (FOXA1) and silencing by CpG methylation is associated with epithelial-mesenchymal transition and metastasis of colorectal cancer. Molecular Biomedicine. 6(1). 133–133.

Chen, Xueyan, Weilin Wu, Ji-Hak Jeong, et al.. (2024). Cytokines-activated nuclear IKKα-FAT10 pathway induces breast cancer tamoxifen-resistance. Science China Life Sciences. 67(7). 1413–1426. 3 indexed citations

Rokavec, Matjaž, et al.. (2023). Development and Validation of a 15-gene Expression Signature with Superior Prognostic Ability in Stage II Colorectal Cancer. Cancer Research Communications. 3(8). 1689–1700. 3 indexed citations

Bouznad, Nassim, Matjaž Rokavec, Meryem Gülfem Öner, & Heiko Hermeking. (2023). miR-34a and IRE1A/XBP-1(S) Form a Double-Negative Feedback Loop to Regulate Hypoxia-Induced EMT, Metastasis, Chemo-Resistance and Autophagy. Cancers. 15(4). 1143–1143. 11 indexed citations

Rokavec, Matjaž, et al.. (2023). Squalene epoxidase/SQLE is a candidate target for treatment of colorectal cancers with p53 mutation and elevated c-MYC expression. International Journal of Biological Sciences. 19(13). 4103–4122. 9 indexed citations

Rokavec, Matjaž, et al.. (2023). Curcumin activates a ROS/KEAP1/NRF2/miR-34a/b/c cascade to suppress colorectal cancer metastasis. Cell Death and Differentiation. 30(7). 1771–1785. 124 indexed citations breakdown →

Tschurtschenthaler, Markus, Matjaž Rokavec, Miguel G. Silva, et al.. (2022). SMAD4 Loss Induces c-MYC–Mediated NLE1 Upregulation to Support Protein Biosynthesis, Colorectal Cancer Growth, and Metastasis. Cancer Research. 82(24). 4604–4623. 19 indexed citations

Bouznad, Nassim, Debora Garzetti, Matjaž Rokavec, et al.. (2022). CCL17 Promotes Colitis-Associated Tumorigenesis Dependent on the Microbiota. The Journal of Immunology. 209(11). 2227–2238. 3 indexed citations

Rokavec, Matjaž, et al.. (2022). Meta-analysis of miR-34 target mRNAs using an integrative online application. Computational and Structural Biotechnology Journal. 21. 267–274. 7 indexed citations

10.

Chou, Jinjiang, et al.. (2022). AP4 suppresses DNA damage, chromosomal instability and senescence via inducing MDC1/Mediator of DNA damage Checkpoint 1 and repressing MIR22HG/miR-22-3p. Molecular Cancer. 21(1). 120–120. 36 indexed citations

11.

Kaller, Markus, et al.. (2020). Characterization of a p53/miR-34a/CSF1R/STAT3 Feedback Loop in Colorectal Cancer. Cellular and Molecular Gastroenterology and Hepatology. 10(2). 391–418. 74 indexed citations

12.

Rokavec, Matjaž, David Horst, & Heiko Hermeking. (2017). Cellular Model of Colon Cancer Progression Reveals Signatures of mRNAs, miRNA, lncRNAs, and Epigenetic Modifications Associated with Metastasis. Cancer Research. 77(8). 1854–1867. 79 indexed citations

13.

Li, Huihui, Matjaž Rokavec, Longchang Jiang, David Horst, & Heiko Hermeking. (2017). Antagonistic Effects of p53 and HIF1A on microRNA-34a Regulation of PPP1R11 and STAT3 and Hypoxia-induced Epithelial to Mesenchymal Transition in Colorectal Cancer Cells. Gastroenterology. 153(2). 505–520. 132 indexed citations

14.

Rokavec, Matjaž, Markus Kaller, David Horst, & Heiko Hermeking. (2017). Pan-cancer EMT-signature identifies RBM47 down-regulation during colorectal cancer progression. Scientific Reports. 7(1). 4687–4687. 74 indexed citations

15.

Rokavec, Matjaž, Meryem Gülfem Öner, & Heiko Hermeking. (2015). lnflammation-induced epigenetic switches in cancer. Cellular and Molecular Life Sciences. 73(1). 23–39. 46 indexed citations

16.

Rokavec, Matjaž, Huihui Li, Jiang Lin, & Heiko Hermeking. (2014). The p53/miR-34 axis in development and disease. Journal of Molecular Cell Biology. 6(3). 214–230. 280 indexed citations

17.

Hermeking, Heiko, Matjaž Rokavec, Huihui Li, & Longchang Jiang. (2014). The p53/microRNA connection in gastrointestinal cancer. Clinical and Experimental Gastroenterology. 7. 395–395. 44 indexed citations

18.

Rokavec, Matjaž, Weilin Wu, & Jun‐Li Luo. (2012). IL6-Mediated Suppression of miR-200c Directs Constitutive Activation of Inflammatory Signaling Circuit Driving Transformation and Tumorigenesis. Molecular Cell. 45(6). 777–789. 127 indexed citations

19.

Kaipparettu, Benny Abraham, Simeen Malik, Santhi D. Konduri, et al.. (2008). Estrogen‐mediated downregulation of CD24 in breast cancer cells. International Journal of Cancer. 123(1). 66–72. 38 indexed citations

20.

Rokavec, Matjaž, Christina Justenhoven, Werner Schroth, et al.. (2007). A Novel Polymorphism in the Promoter Region of ERBB4 Is Associated with Breast and Colorectal Cancer Risk. Clinical Cancer Research. 13(24). 7506–7514. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact